|
市場調查報告書
自動細菌檢查市場
Automated Microbial Testing Markets
|
自動細菌檢查市場 是由出版商Trimark Publications在2010年10月所出版的。
這份英文市場調查報告書包含104 Pages 價格從美金1999起跳。
本報告，將自動細菌檢查市場分成4個區塊，彙整了該市場的規模與成長展望、美國以及全球的業績動向，由下列摘要形式闡述。 封面圖片：  第1章 概要
第2章 自動細菌檢查的簡介
- 標準培養技術的極限
- 自動細菌檢查的優點
- 自動細菌檢查系統的目的
- 細菌的檢出
- 細菌的定量評估
- 細菌的辨識
- 對抗生素之抗藥性的檢出
- 檢體加工與準備
第3章 自動細菌検査市場
- 市場概要：商業案例
- 臨床診斷市場
- 產業界的細菌學市場
- 競爭環境與市佔率
- 全球市場分析
第4章 技術平台與參與企業
- 檢測儀器檢視
- 自動細胞培養
- 自動生化學分析
- 自動基因分析
- 自動免疫分析
第5章 影響自動細菌檢出的重要動向
- 對抗生素的抗藥性增大
- 流感以及其他的感染病
- 對食品、藥劑安全性的擔憂
- 對於生物恐怖主義的安全性
- 法規環境
- 商業環境
- 新機會與策略性建議
第6章 企業檔案資料
圖表
Abstract
Microorganisms are ubiquitous and may be found in almost every environment on
earth. As such, they are a diverse group with an assortment of genotypic and
phenotypic features and varying growth and reproduction requirements. There is
continual interaction between humans and microbes, ranging from
disease-causing pathogenic organisms invading the human body to microorganisms
harnessed by humans to aid in the fermentation of food products. The detection
and characterization of these organisms enables us to better understand how to
manipulate and exert some control over their impact on our lives and welfare.
This TriMark Publications report describes the specific segment of the in
vitro diagnostics (IVD) market known as the diagnostic microbiology and
focuses primarily on the automated microbial testing systems. Within medical
diagnostics, automated microbial testing for infectious disease-causing
organisms offers one of the brightest areas for growth and innovation. The
confluence of breakthroughs in genomics and proteomics--as well as the
development of microarray devices--have led the microbiology market to accept
the power of advanced analytical techniques for the diagnosis and treatment of
infectious disease. For this analysis, the automated microbial testing market
has been divided into the following segments for this examination: 1)
microbial detection, 2) microbial enumeration, 3) microbial identification and
4) detection of antibiotic resistance. This report analyzes the size and
growth of the automated microbial testing market in its applications for
infectious disease detection and therapy, examining the factors that influence
the various market segments and the dollar volume of sales, both in the U.S.
and worldwide.
Report Statistics
- Publication Date: 01-AUG-10
- Pages: 104
- Format: PDF document
Table of Contents
1. Overview
- 1.1 Statement of Report
- 1.2 About this Report
- 1.3 Scope of the Report
- 1.4 Objectives
- 1.5 Methodology
- 1.6 Executive Summary
2. Introduction to Automated Microbial Testing
- 2.1 Limitations of Standard Culturing Techniques
- 2.2 Advantages of Automated Microbial Testing
- 2.3 Objectives of Automated Microbial Testing Systems
- 2.3.1 Microbial Detection
- 2.3.2 Microbial Quantitation
- 2.3.3 Microbial Identification
- 2.3.4 Detection of Antibiotic Resistance
- 2.4 Specimen Processing/Preparation
3. Automated Microbial Testing Market
- 3.1 Market Overview-A Business Case for Automated Microbial Testing
- 3.2 Clinical Diagnostics Market
- 3.2.1 Major Market Segments
- 3.2.1.1 Hospital Market
- 3.2.1.2 Independent Clinical Laboratory Market
- 3.2.1.3 Public Health Laboratory Market
- 3.2.1.4 Blood Banks
- 3.2.2 Overview of Clinical Specimen Types
- 3.2.2.1 Importance of Specimen Collection and Transport
- 3.2.3 Sales Projections of Major Clinical Applications
- 3.2.3.1 Blood Culture
- 3.2.3.2 Urine Screening
- 3.2.3.3 Microbial Identification and Antibiotic Susceptibility
- 3.3 Industrial Microbiology Market
- 3.3.1 Food Testing Market
- 3.3.2 Pharmaceutical Testing Market
- 3.3.3 Biodefense and Water Monitoring Market
- 3.4 Competitive Landscape and Market Share Analysis of Automated
Microbiology Products
- 3.5 Global Market Analysis
4. Technology Platforms and Industry Players
- 4.1 Instrumentation Review
- 4.1.1 Automated Cell Culturing
- 4.1.2 Automated Biochemical Assays
- 4.1.3 Automated Genetic-based Assays
- 4.1.4 Automated Immunological Assays
5. Important Trends Affecting Automated Microbial Detection
- 5.1 Increase in Antibiotic Resistance
- 5.2 Influenza and Other Infectious Diseases
- 5.3 Concerns about Food and Drug Safety
- 5.4 Security against Bioterrorism
- 5.5 Regulatory Landscape
- 5.6 Business Landscape
- 5.6.1 Technology and Market Trends
- 5.6.1.1 Technology Trends
- 5.6.1.2 Specific New Instrument Opportunities
- 5.6.2 Potential Market Entry Barriers and Risks
- 5.6.3 Alternative Market Penetration Strategies
- 5.6.4 Business Planning Issues and Concerns
- 5.6.5 Partnering
- 5.6.6 Competitive Situation
- 5.6.6.1 Primary Competitors
- 5.6.6.2 Industry Challenges and Strategic Recommendations
- 5.6.6.3 Commercialization of Automated Microbial Testing Products
- 5.6.7 Intellectual Property Rights
- 5.7 New Opportunities and Strategic Recommendations
- 5.7.1 Specific Opportunities for Automated Instrumentation Systems with
Significant Market Appeal During the Next Five Years
- 5.7.2 Developments for Microbial Sensitivity Instrumentation Products
- 5.7.3 Market Penetration Strategies for Microbial Susceptibility Testing
- 5.7.4 Automated Microbial Testing Sector Commercial Developments
6. Company Profiles
- 6.1 Abbott Laboratories
- 6.2 AES Chemunex
- 6.3 Advanced Analytical Technologies, Inc.
- 6.4 Applied Biosystems (Part of Life Technologies Corporation)
- 6.5 Becton Dickinson and Company
- 6.6 bioMerieux
- 6.7 Celsis International plc.
- 6.8 Cepheid
- 6.9 Dupont Qualicon
- 6.10 Eiken Chemical Co., Ltd.
- 6.11 Gen-Probe, Inc.
- 6.12 Giles Scientific
- 6.13 Lonza Group Ltd.
- 6.14 3M
- 6.15 Merlin Diagnostika GmbH
- 6.16 MIDI, Inc.
- 6.17 Millipore Corp.
- 6.18 Pall Corporation
- 6.19 PDS
- 6.20 Roche Ltd.
- 6.21 Siemens Healthcare Diagnostics
- 6.22 TREK Diagnostic Systems (Part of Magellan Biosciences, Inc.)
INDEX OF FIGURES
- Figure 3.1: World Market for Treatments of Infectious Diseases, 2008-2014
- Figure 3.2: Global Microbiology Market by Region, 2009
- Figure 3.3: Microbiology Market by Sector, 2003-2013
- Figure 3.4: Molecular Diagnostics Market Segmentation
- Figure 3.5: U.S. Lab Market Share by Test Volume, 2009
- Figure 3.6: Percentage of Clinical Samples Containing Pathogens by
Specimen Type
- Figure 3.7: Total Micro Testing Process Flow Chart
- Figure 3.8: Rapid and Traditional Industrial Microbiology Testing Volume,
2003-2013
- Figure 3.9: Rapid and Traditional Industrial Microbiology Testing as
Percentage of Total, 2003-2013
- Figure 3.10: Food Microbiology Testing Sample Collection Points
- Figure 3.11: Microbiology Test Volume in the Food Industry, 2005-2013
- Figure 3.12: Percentage of Pharmaceutical Manufacturers Using Rapid
Microbiological Methods
- Figure 3.13: Flowchart of Steps for Implementation of Rapid Microbial
Methods
- Figure 3.14: Clinical Bacteriology Market Size by Region
- Figure 3.15: Industrial Applications Market by Region
- Figure 5.1: Incidence Rates of Infectious MRSA Infections by Age
- Figure 5.2: Global Frequency of Vancomycin-resistant Enterococcus, 2006
- Figure 5.3: Number of Reported and Confirmed Cases of Influenza H1N1
Strain Worldwide, 2009
- Figure 5.4: Status of H5N1 Avian Influenza, 2009
- Figure 5.5: Global Trend of HIV Infection, 1991-2007
INDEX OF TABLES
- Table 3.1: Global Microbiology Market Size, 2003-2015
- Table 3.2: Automated Microbial Testing Market Segments Overview
- Table 3.3: Global Microbiology Market by Operational Sector, 2003-2013
- Table 3.4: Medical Instrument Automation Technologies Market: Diagnostic
Applications, 2003-2015
- Table 3.5: Key Drivers in the Automated Microbial Testing Market
- Table 3.6: Key Barriers to the Automated Microbial Testing Market
- Table 3.7: Global Clinical In Vitro Diagnostics Markets by Assay Type
- Table 3.8: Clinical Bacteriology Market Size by Testing Method
- Table 3.9: Global Market for Detection of Infectious Diseases Using
Molecular Diagnostic Methods, 2006-2015
- Table 3.10: Share of Molecular Diagnostics Market Size Testing by Type
- Table 3.11: Global Market for Blood-Screening Diagnostic Testing, 2000-2009
- Table 3.12: U.S. Market for Blood-Screening Diagnostic Testing, 2000-2009
- Table 3.13: Overview of Specimens for Culture
- Table 3.14: Global Urinalysis Market
- Table 3.15: Global Microbiology ID/AST Market, 2002-2009
- Table 3.16: Global Market Segments Performing Microbiology Tests by Test
Volume
- Table 3.17: Global Food Microbiology Market, 2005-2013
- Table 3.18: Traditional and Rapid Microbiology Testing in the Food
Industry, 2005-2013
- Table 3.19: RMM in Pharmaceutical Testing Market by Type
- Table 3.20: U.S. Market for Biological Threat Detection Testing, 2000-2010
- Table 3.21: Microbiology Market Share Profile, 2009
- Table 3.22: ID/AST Market Share Profile, 2009
- Table 3.23: Global IVD Growth Rates, 2009-2014
- Table 4.1: Automated Cell Culturing
- Table 4.2: Automated Biochemical Assays
- Table 4.3: Automated Genetic-based Assays
- Table 4.4: Automated Immunological Assays
- Table 5.1: Major Pathogens Identified in the Last 30 Years
- Table 5.2: Global Market Potential for TB Diagnostic Testing, 2000-2010
- Table 5.3 Key Regulatory Requirements for Microbial Testing Instruments
and Reagents
- Table 5.4 Drivers of the Microbial Testing Market
- Table 5.5: Technology Trends in Microbial Susceptibility Testing
- Table 5.6: Market Trends in Microbial Susceptibility Testing
- Table 5.7 Microbial Testing Markets: Market Drivers Ranked in Order of
Impact
- Table 5.8 Microbial Testing Markets: Market Restraints Ranked in Order of
Impact
- Table 5.9: Companies that Offer Products for Automated Microbial Testing
- Table 5.10: Competitive Factors in the Automated Microbial Testing
Diagnostics Infectious Disease Market
- Table 5.11: Infectious Disease Testing Market: Strategic Recommendations
on Sector Business Functions
- Table 5.12: Automated Microbial Testing Market: Impact of Top Industry
Challenges (U.S.)
- Table 6.1: Products Marketed by Abbott in the Diagnostic Market
|
